Description
Abnormal CBD-d3, CAY10429-d3 Item No. 10009523, 100 µg
Technical Information
- Abn-CBD-d3
- Abnormal Cannabidiol-d3
- DMF: 50 mg/ml
- DMSO: 60 mg/ml
- DMSO:PBS (pH 7.2)(1:3): 0.25 mg/ml
- Ethanol: 35 mg/ml
Shipping & Storage Information
Product Description
CAY10429-d3 contains three deuterium atoms at the terminal methyl position. It is intended for use as an internal standard for the quantification of CAY10429 by GC- or LC-mass spectrometry. Traditionally, the activity of cannabinoid (CB) agonists was thought to be transduced by a pair of G protein-coupled receptors, CB1 and CB2.1 CAY10429 (abnormal cannabidiol) is a synthetic regioisomer of cannabidiol that fails to elicit either CB1 or CB2 responsiveness and is without psychotropic activity. CAY10429 induces endothelium-dependent vasodilation via a CB1/CB2/nitric oxide-independent mechanism.2 At a dose of 20 µg/g in rats, CAY10429 showed hypotensive activity that could not be antagonized by cannabidiol or SR141716A. CAY10429 is therefore believed to activate a third type of CB receptor, provisionally called the non-CB1/CB2 endocannabinoid receptor. CAY10429 also acts via these receptors to regulate the migratory activity of murine BV-2 microglial cells, with an EC50 value of 600 nM.3
WARNING This product is not for human or veterinary use.